EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY 4.0

Novel IgG and IgA autoantibodies validated in two independent cohorts are associated with disease activity and determine organ manifestations in systemic lupus erythematosus: implications for anti-LIN28A, anti-HMGN5, anti-IRF5, and anti-TGIF1

Julius Lindblom, Denis Lagutkin, Natalia Sherina, Helena Idborg, Lorenzo Beretta, Maria Orietta Borghi, PRECISESADS Clinical Consortium, Janique M Peyper, Guillermo Barturen, Per-Johan Jakobsson, Marta E Alarcón-Riquelme, Dionysis Nikolopoulos und 1 weitere

Annals of the Rheumatic Diseases · 2025-07 · 84 (7) · 1164-1179

DOI: 10.1016/j.ard.2025.04.008 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Annals of the Rheumatic Diseases, 2025-07. Verfasst von Julius Lindblom und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, and Karolinska University Hospital, Stockholm, Sweden; Center for Mole…. Hauptthemen laut MEDLINE: Autoantibodies, Immunoglobulin A, Immunoglobulin G, Lupus Erythematosus, Systemic. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Rheumatism Association, Hôpitaux Universitaires de Genève, Université Catholique de Louvain.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: This study aimed to identify and validate novel autoantibodies that reflect global and organ-specific disease activity in systemic lupus erythematosus (SLE). METHODS: Plasma samples were screened for IgG and IgA seroreactivity against 1609 protein autoantigens using a microarray (i-Ome Discovery; Sengenics). We determined differentially abundant autoantibodies (daAAbs) in patients with SLE vs healthy controls within a discovery (n = 196 vs n = 110; NTC02890121) and an independent validation cohort (n = 30 vs n = 83; NCT02890134) from the European PRECISESADS project. Validated daAAbs were analysed in relation to global and organ-specific disease activity using linear and logistic regression, along with daAAb target pathway enrichment analysis. RESULTS: We validated 89 IgG and 66 IgA daAAbs. IgG anti-LIN28A, IgG anti-HMGN5, and both isotypes for anti-IRF5 and anti-TGIF1 were associated with a SLE disease activity index 2000 score of ≥10, negatively associated with lupus low disease activity state, and highly prevalent in subgroups with active disease across organ manifestations. IgG anti-LIN28A levels exceeded the cutoff for positivity in 53% of patients with central nervous system (CNS) involvement, a prevalence higher than that observed for anti-double-stranded DNA (20%) and 47% of patients with renal activity. A cluster of IgG and IgA daAAbs against RNA-binding proteins, including anti-LIN28A, was linked to CNS involvement. IgA anti-FOSL2 was elevated uniquely in patients with musculoskeletal activity. Enriched pathways involving DNA binding and repair showed considerable overlap across manifestations. CONCLUSIONS: Novel IgG and IgA autoantibodies, including IgG anti-LIN28A, IgG anti-HMGN5, IgG and IgA anti-IRF5, and IgG and IgA anti-TGIF1 were associated with SLE disease activity and highly abundant across organ manifestations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutoantibodiesImmunoglobulin AImmunoglobulin GLupus Erythematosus, SystemicAdultFemaleHumansMaleMiddle AgedAutoantigensCase-Control StudiesInterferon Regulatory FactorsRepressor ProteinsRNA-Binding ProteinsSeverity of Illness IndexObservational Studies as TopicMulticenter Studies as Topic

Substanzen

AutoantibodiesAutoantigensImmunoglobulin AImmunoglobulin GInterferon Regulatory FactorsIRF5 protein, humanRepressor ProteinsRNA-Binding Proteins

Autor:innen und Institutionen

  • Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, and Karolinska University Hospital, Stockholm, Sweden; Center for Molecular Medicine, Stockholm, Sweden.
  • Referral Center for Systemic Autoimmune Diseases, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Italy.
  • Department of Clinical Sciences and Community Health, Università Degli Studi di Milano, Milan, Italy; IRCCS, Istituto Auxologico Italiano, Milan, Italy.
  • Sengenics Corporation Pte Ltd, Singapore, Singapore.
  • GENYO, Centre for Genomics and Oncological Research: Pfizer, University of Granada/Andalusian Regional Government, Granada, Spain, Medical Genomics, Granada, Spain; Department of Genetics, Faculty of Sciences, Universit…
  • GENYO, Centre for Genomics and Oncological Research: Pfizer, University of Granada/Andalusian Regional Government, Granada, Spain, Medical Genomics, Granada, Spain; Department of Environmental Medicine, Karolinska Insti…

Förderung

  • Swedish Rheumatism Association
  • Hôpitaux Universitaires de Genève
  • Université Catholique de Louvain
  • Hospital Clínic de Barcelona
  • Örebro Universitet
  • Centro Hospitalar Universitário do Porto
  • The Key Find
  • Medizinischen Hochschule Hannover

Zitieren

APA

Lindblom, J., Lagutkin, D., Sherina, N., Idborg, H., Beretta, L., Borghi, M. O., PRECISESADS Clinical Consortium, Peyper, J. M., Barturen, G., Jakobsson, P. J., Alarcón-Riquelme, M. E., Nikolopoulos, D., & Parodis, I. (2025). Novel IgG and IgA autoantibodies validated in two independent cohorts are associated with disease activity and determine organ manifestations in systemic lupus erythematosus: implications for anti-LIN28A, anti-HMGN5, anti-IRF5, and anti-TGIF1. Annals of the Rheumatic Diseases, 84(7), 1164-1179. https://doi.org/10.1016/j.ard.2025.04.008

Vancouver

Lindblom J, Lagutkin D, Sherina N, Idborg H, Beretta L, Borghi MO, et al. Novel IgG and IgA autoantibodies validated in two independent cohorts are associated with disease activity and determine organ manifestations in systemic lupus erythematosus: implications for anti-LIN28A, anti-HMGN5, anti-IRF5, and anti-TGIF1. Annals of the Rheumatic Diseases. 2025;84(7):1164-1179. doi:10.1016/j.ard.2025.04.008

BibTeX
@article{Lindblom2025,
  author = {Lindblom, Julius and Lagutkin, Denis and Sherina, Natalia and Idborg, Helena and Beretta, Lorenzo and Borghi, Maria Orietta and PRECISESADS Clinical Consortium, PRECISESADS Clinical Consortium and Peyper, Janique M and Barturen, Guillermo and Jakobsson, Per-Johan and Alarcón-Riquelme, Marta E and Nikolopoulos, Dionysis and Parodis, Ioannis},
  title = {Novel IgG and IgA autoantibodies validated in two independent cohorts are associated with disease activity and determine organ manifestations in systemic lupus erythematosus: implications for anti-LIN28A, anti-HMGN5, anti-IRF5, and anti-TGIF1},
  journal = {Annals of the Rheumatic Diseases},
  year = {2025},
  volume = {84},
  number = {7},
  pages = {1164--1179},
  doi = {10.1016/j.ard.2025.04.008}
}
Kostenlos starten →